Complete pathological regression of hepatocellular carcinoma with portal vein thrombosis treated with sorafenib

Complete pathological regression of hepatocellular carcinoma with portal vein thrombosis treated with sorafenib

Sorafenib is a molecular-targeted therapy used in palliative treatment of advanced hepatocellular carcinoma (HCC) in Child-Pugh A patients. We describe the case of a patient who presented with a large HCC in the left liver associated with portal vein thrombosis (PVT). After 9 months of sorafenib tre...

Full description

Bibliographic Details
Main Authors: Kermiche-Rahali, Sabrina, Di Fiore, Aude, Drieux, Fanny, Di Fiore, Frédéric, François, Arnaud, Scotté, Michel
Format: Online
Language:English
Published: BioMed Central 2013
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3735470/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3735470/

Similar Items